The legacy of Viagra, and its developer copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in income, its intellectual property lapse created a wave of generic competition , significantly diminishing its dominance. While some businesses may attempt to capitalize on male sexual dysfunction, the